Relatioship between activation of FGFR-mediated signalling and loss of progesterone receptor in estrogen receptor-positive breast cancer: implications for tumour prognostication and therapy.

2015/17/B/NZ4/02157

Keywords

Descriptors

  • NZ4_5: Patomorfologia
  • NZ3_1: Biologia komórki

Panel

NZ4 – Biology of tissues, organs and organisms: morphology and functions of animal's and human's systems, organs and organisms, experimental medicine, basics of neurology

Host institution

Uniwersytet Medyczny w Łodzi, Katedra Onkologii, Zakład Patologii

Voivodeship: łódzkie

Other projects carried out by the institution »

Principal investigator (from the host institution)

prof. Radzisław Kordek

Number of co-investigators in the project: 6

Call

OPUS 9 – announced on 2015-03-16

Amount awarded
1 079 200 PLN
Project start date
2016-03-09
Project end date
2021-03-08
Project duration
60 months (the same as in the proposal)
Project status
Project settled

Project description

Download the project description in a pdf file

Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

Equipment purchased [PL]

  1. CFX Connect System 2.
  2. Przystawka do fitra wody. Cost: 16 000 PLN
  3. analogowy blok grzewczy.
  4. b.d..
  5. chłodziarka laboratoryjna.
  6. hulamixer.
  7. spektrofotometr NanoDrop.
  8. statyw magnetyczny.
  9. wirówka.
  10. wizualizator chemiluminescencji. Cost: 77 000 PLN
  11. wytrząsarka laboratoryjna. Cost: 7 000 PLN
  12. wytrząsarka o ruchu okrężno-kołowym.

Information in the final report

Publication in academic press/journals (5)

  1. Hormonal Receptor Status Determines Prognostic Significance of FGFR2 in Invasive Breast Carcinoma.

    Authors:
    Braun, M.; Piasecka, D.; Tomasik, B.; Mieczkowski, K.; Stawiski, K.; Zielinska, A.; Kopczynski, J.; Nejc, D.; Kordek, R.; Sadej, R.; Romanska, H.M.
    Academic press:
    Cancers (year: 2020, volume: 12, pages: 46040), Publisher: MDPI
    Status:
    Published
    DOI:
    10.3390/cancers12092713 – link to the publication
  2. FGFR2-driven signalling abrogates tamoxifen effect on ERalpha-positive breast cancer cells

    Authors:
    Lukasz Turczyk; Kamila Kitowska; Magdalena Mieszkowska; Kamil Mieczkowski; Dominika Czaplinska; Dominika Piasecka; Radzislaw Kordek; Andrzej Skladanowski; Piotr Potemski; Hanna Romanska; Rafal Sadej
    Academic press:
    Neoplasia (year: 2017, volume: 19, pages: 791-804), Publisher: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.neo.2017.07.006 – link to the publication
  3. FGFs/FGFRs-dependent signalling in regulation of steroid hormone receptors - implications for therapy of luminal breast cancer

    Authors:
    Piasecka Dominika, Braun Marcin, Kitowska Kamila, Mieczkowski Kamil, Kordek Radzislaw, Sadej Rafal, Romanska Hanna
    Academic press:
    Journal of Experimental & Clinical Cancer Research (year: 2019, volume: 38, pages: 230), Publisher: BMC Springer Nature
    Status:
    Published
    DOI:
    10.1186/s13046-019-1236-6 – link to the publication
  4. Fibroblast growth factor signalling induces loss of progesterone receptor in breast cancer cells.

    Authors:
    Piasecka D, Kitowska K, Czaplinska D, Mieczkowski K, Mieszkowska M, Turczyk L, Skladanowski AC, Zaczek AJ, Biernat W, Kordek R, Romanska HM, Sadej R
    Academic press:
    Oncotarget (year: 2016, volume: 7, pages: 86011-86025), Publisher: Impact Journals, LLC
    Status:
    Published
    DOI:
    10.18632/oncotarget.13322 – link to the publication
  5. MicroRNAs in regulation of triple-negative breast cancer progression

    Authors:
    Piasecka, Dominika, Braun, Marcin, Kordek, Radzislaw, Sadej, Rafal, Romanska, Hanna
    Academic press:
    Journal of Cancer Research and Clinical Oncology (year: 2018, volume: 144(8), pages: 1401-1411), Publisher: Springer
    Status:
    Published
    DOI:
    10.1007/s00432-018-2689-2 – link to the publication

« New search

Graphic design and implementation: Jakub Piotrowski